Endovascular Management of Venous Thromboembolic Disease in the Oncologic Patient Population
- 7 February 2022
- journal article
- review article
- Published by Springer Nature in Current Oncology Reports
- Vol. 24 (3) , 351-362
Abstract
Purpose of Review Venous thromboembolic disease causes significant mortality and morbidity in the oncologic patient population. Recently, minimally invasive endovascular technologies have been developed as an adjunct to antithrombotic therapy for the management of DVT and PE. The current and potential roles for endovascular treatment of cancer-associated venous thromboembolism (VTE) will be reviewed in this article. Recent Findings The recent NCCN guidelines recommend endovascular therapy in patients eligible for therapeutic anticoagulation who present with life-, organ-, or limb-threatening thrombosis. However, symptomatic non-life-threatening VTE can negatively affect QOL and physical function, both of which have prognostic implications in the cancer population. Endovascular therapies have been shown to improve physical function and QOL in prospective trials performed in a non-oncologic patient population as well as small retrospective studies in the cancer population. Summary In addition to treating life- and limb-threatening thrombosis, endovascular therapy for VTE can improve QOL and physical function in comparison to anticoagulation alone. Prospective trials are warranted to assess the benefit of endovascular therapy for quality of life-years, performance status, and overall survival in the oncologic patient population.Keywords
This publication has 77 references indexed in Scilit:
- Risk of intracranial hemorrhage with anticoagulation therapy in melanoma patients with brain metastasesMelanoma Research, 2012
- Derivation and validation of a multivariate model to predict mortality from pulmonary embolism with cancer: The POMPE-C toolThrombosis Research, 2012
- Venous thromboembolism and prognosis in cancerThrombosis Research, 2010
- Development and validation of a predictive model for chemotherapy-associated thrombosisBlood, 2008
- Predicting adverse outcome in outpatients with acute deep vein thrombosis. Findings from the RIETE RegistryJournal of Vascular Surgery, 2006
- Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosisBlood, 2002
- Therapy of venous thromboembolism in patients with brain metastasesCancer, 1994
- Risk of intracranial hemorrhage in glioma patients receiving anticoagulant therapy for venous thromboembolismJournal of Neurosurgery, 1987
- Incidence and treatment of peripheral venous thrombosis in patients with gliomaAnnals of Neurology, 1983
- Spontaneous intracerebral hematoma caused by cerebral neoplasmsJournal of Neurosurgery, 1975